Adagio Medical Holdings, Inc. has announced plans for a special meeting of stockholders to discuss a proposed reverse stock split. This decision comes as the company seeks to maintain compliance with Nasdaq listing requirements. The meeting is set to take place virtually on December [date], 2026, and is crucial for the company's future on the Nasdaq exchange.

Adagio Medical Holdings, Inc., incorporated in Delaware, operates in the surgical and medical instruments and apparatus sector. The company trades on Nasdaq under the ticker symbol ADGM. This preliminary proxy statement, filed on November 10, 2026, outlines the agenda for the upcoming special meeting and highlights the importance of the proposed reverse stock split.

The filing indicates that the reverse stock split could be executed at a ratio of up to 1-for-1,000. The exact ratio will be determined by the Board of Directors, allowing flexibility to respond to market conditions. This move is essential for the company to meet the minimum bid price requirement set by Nasdaq.

In addition to the reverse stock split proposal, the meeting will also address the possibility of adjournment to solicit additional proxies if necessary. This could affect stockholders who may need to vote on the proposals, particularly those who hold shares through brokers or other intermediaries.

Looking ahead, stockholders are encouraged to attend the virtual meeting and participate in the voting process. The filing does not specify any further actions following the meeting, but the outcomes could significantly impact Adagio's compliance with Nasdaq and its operational strategy moving forward.